×

Marathon's $89K/year drug

1:23 PM ET Mon, 13 Feb 2017

Marathon Pharmaceuticals is under heavy fire since it announced it would be charging $89,000/year for its Duchenne Muscular Dystrophy drug. CNBC's Meg Tirrell reports.